Musculoskeletal system-bone and bone marrow and intraosseous, percutaneous approach

85813800 Category Share

Musculoskeletal system-bone and bone marrow and intraosseous, percutaneous approach is an EFRIS commodity class (code 85813800) under Administrative interventions or procedures, physiological systems and anatomical regions, introduction and irrigation and circulatory in Uganda Revenue Authority's e-invoicing system.

35 items in this category

• 85813802Introduction of analgesics, hypnotics, sedatives into bones, percutaneous approach
  Exempt
• 85813823Introduction of analgesics, hypnotics, sedatives into joints, percutaneous approach
  Exempt
• 85813810Introduction of anti-inflammatory into bones, percutaneous approach
  Exempt
• 85813830Introduction of anti-inflammatory into joints, percutaneous approach
  Exempt
• 85813801Introduction of destructive agent into bones, percutaneous approach
  Exempt
• 85813821Introduction of destructive agent into joints, percutaneous approach
  Exempt
• 85813808Introduction of electrolytic and water balance substance into bones, percutaneous approach
  Exempt
• 85813828Introduction of electrolytic and water balance substance into joints, percutaneous approach
  Exempt
• 85813835Introduction of liquid brachytherapy radioisotope into joints, percutaneous approach
  Exempt
• 85813807Introduction of local anesthetic into bones, percutaneous approach
  Exempt
• 85813827Introduction of local anesthetic into joints, percutaneous approach
  Exempt
• 85813817Introduction of monoclonal antibody into bone marrow, percutaneous approach
  Exempt
• 85813813Introduction of monoclonal antibody into bones, percutaneous approach
  Exempt
• 85813833Introduction of monoclonal antibody into joints, percutaneous approach
  Exempt
• 85813809Introduction of nutritional substance into bones, percutaneous approach
  Exempt
• 85813829Introduction of nutritional substance into joints, percutaneous approach
  Exempt
• 85813811Introduction of other anti-infective into bones, percutaneous approach
  Exempt
• 85813819Introduction of other anti-infective into joints, open approach
  Exempt
• 85813831Introduction of other anti-infective into joints, percutaneous approach
  Exempt
• 85813818Introduction of other antineoplastic into bone marrow, percutaneous approach
  Exempt
• 85813814Introduction of other antineoplastic into bones, percutaneous approach
  Exempt
• 85813834Introduction of other antineoplastic into joints, percutaneous approach
  Exempt
• 85813803Introduction of other diagnostic substance into bones, percutaneous approach
  Exempt
• 85813824Introduction of other diagnostic substance into joints, percutaneous approach
  Exempt
• 85813822Introduction of other gas into joints, percutaneous approach
  Exempt
• 85813816Introduction of other therapeutic substance into bone marrow, percutaneous approach
  Exempt
• 85813805Introduction of other therapeutic substance into bones, percutaneous approach
  Exempt
• 85813826Introduction of other therapeutic substance into joints, percutaneous approach
  Exempt
• 85813812Introduction of oxazolidinones into bones, percutaneous approach
  Exempt
• 85813820Introduction of oxazolidinones into joints, open approach
  Exempt
• 85813832Introduction of oxazolidinones into joints, percutaneous approach
  Exempt
• 85813804Introduction of radioactive substance into bones, percutaneous approach
  Exempt
• 85813825Introduction of radioactive substance into joints, percutaneous approach
  Exempt
• 85813806Introduction of recombinant bone morphogenetic protein into bones, percutaneous approach
  Exempt
• 85813815Introduction of recombinant bone morphogenetic protein into joints, percutaneous approach
  Exempt